Maximum Subcutaneous Calcitonin Dose Per Day
The FDA-approved maximum subcutaneous dose of calcitonin-salmon for postmenopausal osteoporosis is 100 IU daily. 1, 2
FDA-Approved Dosing
The official FDA labeling and current clinical practice guidelines consistently specify:
- Subcutaneous (or intramuscular) calcitonin: 100 IU daily 1
- This is the standard approved dose for treatment of postmenopausal osteoporosis
- No higher doses are FDA-approved for subcutaneous administration
Important Clinical Context
Calcitonin should generally NOT be used as first-line therapy for osteoporosis. The 2020 AACE/ACE guidelines explicitly recommend limiting calcitonin use as long-term osteoporosis treatment because more effective agents are available 1. The primary appropriate use is:
- Short-term prescriptions for acute painful vertebral fractures due to potential analgesic effects 1
- Duration should be limited given lack of proven antifracture efficacy for injectable formulations
Critical Safety Considerations
Lack of Efficacy Evidence
- No published studies demonstrate antifracture efficacy for injectable calcitonin 1
- Injectable calcitonin produces only minimal BMD increases at the spine and none at other sites 1
Cancer Risk Signal
A meta-analysis of 21 randomized trials showed higher malignancy incidence in calcitonin-treated patients 1. While the FDA did not establish causality, this reinforces the recommendation to limit use 1.
Pituitary Adenoma Risk
Animal studies showed increased pituitary adenomas in rats at doses as low as 1.7 IU/kg/day (approximately 2 times the maximum recommended human intranasal dose when adjusted for bioavailability) 2.
Common Pitfalls to Avoid
- Do not exceed 100 IU daily subcutaneously - this is the maximum approved dose
- Do not use for long-term osteoporosis management - reserve for short-term analgesia in acute vertebral fractures
- Do not assume equivalence with nasal formulation - nasal calcitonin (200 IU daily) has only ~3-5% bioavailability compared to subcutaneous 2, 3, 4
- Ensure adequate calcium and vitamin D before initiating any osteoporosis therapy
Alternative Considerations
If long-term osteoporosis treatment is needed, consider FDA-approved agents with proven fracture reduction efficacy such as bisphosphonates, denosumab, or anabolic agents rather than calcitonin 1.